Working capital decreased 24.9%
Working capital changed -24.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$5.9B→$4.4B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RIVN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash-flow margin moved 3684 bp lower
Operating cash-flow margin changed -3684 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.67%→-35.17%2 prior comparisons
Free-cash-flow margin moved 2514 bp lower
Free-cash-flow margin changed -2514 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-27.02%→-52.16%2 prior comparisons
Operating income increased 10.4%
Operating income changed +10.4% from the comparable as-filed period.
-$983.0M→-$881.0M2 prior comparisons
Working capital / assets moved 1049 bp lower
Working capital / assets changed -1049 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
38.44%→27.95%4 prior comparisons
R&D / revenue moved 657 bp lower
R&D / revenue changed -657 basis points from the comparable as-filed period.
29.08%→22.51%2 prior comparisons
Receivables / revenue moved 1463 bp higher
Receivables / revenue changed +1463 basis points from the comparable as-filed period.
13.03%→27.66%2 prior comparisons
SBC / revenue moved 184 bp lower
SBC / revenue changed -184 basis points from the comparable as-filed period.
11.17%→9.33%2 prior comparisons
Capital expenditure decreased 18.1%
Capital expenditure changed -18.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$447.0M→$366.0M2 prior comparisons
Current assets decreased 12.3%
Current assets changed -12.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$9.3B→$8.1B4 prior comparisons
Inventory increased 8.6%
Inventory changed +8.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$1.6B→$1.8B4 prior comparisons
Total assets increased 3.4%
Total assets changed +3.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$15.2B→$15.7B4 prior comparisons
Current liabilities increased 9.2%
Current liabilities changed +9.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.4B→$3.7B4 prior comparisons
Current ratio decreased 19.7%
Current ratio changed -19.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
2.71→2.184 prior comparisons
Stock-based compensation increased 15.5%
Stock-based compensation changed +15.5% from the comparable as-filed period.
$174.0M→$201.0M2 prior comparisons
Research & development increased 7.1%
Research & development changed +7.1% from the comparable as-filed period.
$453.0M→$485.0M2 prior comparisons
Selling, general & administrative increased 3.2%
Selling, general & administrative changed +3.2% from the comparable as-filed period.
$554.0M→$572.0M2 prior comparisons
Noncurrent long-term debt increased 0.2%
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$4.4B→$4.4B4 prior comparisons
Capital expenditure decreased 21.6%
Capital expenditure changed -21.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$462.0M→$362.0M3 prior comparisons
Operating cash-flow margin moved 3428 bp lower
Operating cash-flow margin changed -3428 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.91%→-29.37%2 prior comparisons
Free-cash-flow margin moved 2066 bp lower
Free-cash-flow margin changed -2066 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-30.54%→-51.21%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -860.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$64.0M→-$487.0M3 prior comparisons
Trade receivables increased 45.7%
Trade receivables changed +45.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$254.0M→$370.0M4 prior comparisons
Inventory decreased 21.0%
Inventory changed -21.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.1B→$1.7B4 prior comparisons
Current ratio decreased 38.8%
Current ratio changed -38.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
3.44→2.14 prior comparisons
Working capital / assets moved 1961 bp lower
Working capital / assets changed -1961 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
46.02%→26.41%4 prior comparisons
R&D / revenue moved 336 bp lower
R&D / revenue changed -336 basis points from the comparable as-filed period.
31.47%→28.11%2 prior comparisons
Receivables / revenue moved 282 bp higher
Receivables / revenue changed +282 basis points from the comparable as-filed period.
19.49%→22.32%2 prior comparisons
Stock-based compensation increased 19.6%
Stock-based compensation changed +19.6% from the comparable as-filed period.
$189.0M→$226.0M3 prior comparisons
Gross profit changed across a sign change
Gross profit changed +186.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$206.0M→$179.0M2 prior comparisons
Research & development increased 13.7%
Research & development changed +13.7% from the comparable as-filed period.
$410.0M→$466.0M2 prior comparisons
SBC / revenue moved 87 bp lower
SBC / revenue changed -87 basis points from the comparable as-filed period.
14.50%→13.63%2 prior comparisons
Total assets decreased 2.9%
Total assets changed -2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$15.6B→$15.1B4 prior comparisons
Selling, general & administrative increased 10.2%
Selling, general & administrative changed +10.2% from the comparable as-filed period.
$498.0M→$549.0M2 prior comparisons
Cost of revenue decreased 2.0%
Cost of revenue changed -2.0% from the comparable as-filed period.
$1.5B→$1.5B2 prior comparisons
Noncurrent long-term debt increased 0.2%
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$4.4B→$4.4B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.